CC-671

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCC-671

Drug Alias NameCC-671

ClassificationSmall molecules

Mechanisms of ActionPhosphotransferases inhibitorsDual specificity protein kinase TTK inhibitors

TargetsPhosphotransferasesDual specificity protein kinase TTK

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelgene Corp

China Registration ClassN/A

Active CompaniesCelgene Corp

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A